Submitted by Biblioteca da Faculdade de Farmácia (bff@ndc.uff.br) on 2017-04-19T16:57:00Z No. of bitstreams: 1 Pontes, Simone Gomes [Dissertação, 2012].pdf: 1302242 bytes, checksum: 7aab3cecd1b771d41f103c491d846579 (MD5) / Made available in DSpace on 2017-04-19T16:57:00Z (GMT). No. of bitstreams: 1 Pontes, Simone Gomes [Dissertação, 2012].pdf: 1302242 bytes, checksum: 7aab3cecd1b771d41f103c491d846579 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / A dihidroxiacetona (DHA) é uma molécula constituída por três carbonos e não tóxica, utilizada como insumo para as indústrias de cosméticos, fármacos e química fina. É produzida industrialmente por fermentação, utilizando a bactéria Gluconobacter oxydans. Esse processo tem como principal limitação a inibição do crescimento tanto pelo substrato – glicerol – quanto pelo produto – DHA e, por tal, estudos recentes descrevem propostas para melhoria do processo. Sendo a conversão de glicerol a DHA realizada por uma única enzima em uma etapa, o presente trabalho considera que tal processo se enquadra nas definições de uma biotransformação, ou seja, a utilização de um catalisador biológico com o propósito de converter um substrato a um produto estruturalmente similar, através de modificações específicas e utilizando um número limitado de etapas enzimáticas. Dessa forma, neste estudo foram avaliados comparativamente a secagem de células em acetona e, em um segundo momento, a utilização de células de Gluconobacter oxydans previamente crescidas, para a produção de DHA a partir de glicerol. Objetivando contornar o principal problema do processo, que é a inibição do crescimento microbiano pelo substrato e pelo produto, foram testadas duas linhagens. A utilização de células secas em acetona se mostrou possível, porém os resultados não foram reprodutíveis e células previamente crescidas por 24 horas passaram a ser usadas nos experimentos de biotransformação. O pH e a temperatura de reação foram selecionados a partir de um planejamento delineamento composto central rotacional como sendo de 34ºC e pH de 4,5, para G. oxydans CCT 0552 e de 26ºC e pH de 4,5 para G. oxydans CCT 0174. A linhagem G. oxydans CCT 0552 se mostrou mais adequada à oxidação de glicerol à DHA, com aumento do acúmulo de DHA no meio reacional com o tempo (2,1 g/g biomassa) e com a produtividade constante (0,45 g/g biomassa). Foi constatada perda de atividade nas células estocadas por congelamento, o que leva à necessidade de selecionar um melhor método de conservação das células para a utilização na produção / The dihydroxyacetone (DHA) is a non-toxic molecule consisting of three carbons, used in the cosmetics, pharmaceuticals and fine chemicals industry. The DHA is industrially produced by fermentation, using the bacteria Gluconobacter oxydans. The main bottleneck of this process is the growth inhibition by the substrate – glycerol – and the product – DHA. This problem leads recent studies to describe proposals for improving the process. As the conversion of glycerol to DHA is performed by a single enzyme in one step, this study considers that this process fits in the definitions of biotransformation, in other words, the use of a biological catalyst in order to convert a substrate for a structurally similar products, by speficic modifications, and using a limited number of enzymatic steps. Thus, this study were assessed by comparison with drying of cells in acetone and in second stage, the use of previously grown cells of Gluconobacter oxydans for the production of DHA from glycerol. The use of dried cells proved to be possible, but the results were not reproducible and the biotransformation experiments were done with previously grown cells of 24 hours age. . The best pH and temperature for the reaction were selected from a central composite design as being 34o C and pH 4.5 for G. oxydans CCT 0552 and 26o C and pH 4.5 for G. oxydans CCT 0174. The strain G. oxydans CCT 0552 was more suitable for the oxidation of glycerol to DHA, with increased accumulation of DHA in the reaction media (2,1 g/g biomass) and constant productivity (0,45 g/g biomass). Loss of activity was observed in cells stored by freezing, which leads to the need to select a best method of preserving cells for the production

D.Phil. (Biochemistry) / This thesis concerns a study of the effect of isonitrosoacetophenone on plant metabolism. Three different systems were investigated; cultured tobacco and sorghum cells as well as Arabidopsis thaliana plants, and a metabolomic approach was followed. Unlike most scientific studies, metabolomics is a discipline which is not driven by a specific hypothesis, but rather by the obtained data to add scientific insights to the topic under investigation. As such, the current study lacks a definite overarching hypothesis, but specific objectives were outlined and answered in each experimental chapter. This thesis is therefore presented as a compilation of nine chapters in which experimental/research work is described in Chapter 3- 8. It is important to note that each chapter is presented in accordance with the guidelines for the respective journal in which the corresponding manuscript was published or submitted to.

In a program aimed at the identification of compounds responsible for the immunosuppressive and antifertility activities of the perennial twining vine, Tripterygium wilfordii. 5 new and 13 known compounds were isolated from the TRP-4a tissue culture cell line developed from Tripterygium wilfordii. The structures of the new compounds were determined by a combination of spectral analysis, chemical correlation and single crystal X-ray diffraction analysis. 22β-Hydroxy-3-oxoolean-12-en-29-oic acid (137), 22α-hydroxy-3-oxoolean- 12- en-29-oic acid (138) and 3β, 22β-dihydroxyolean-12-en-29-oic acid (139) are new triterpenes possessing an oleanene-type skeleton and were chemically correlated with 3β, 22α-dihydroxyolean-12-en-29-oic acid (51), the structure of which was confirmed by single crystal X-ray diffraction analysis. Oleanolic acid (127), β-sitosterol (128) and polpunonic acid (55), were isolated previously from the TRP-4a cell line in earlier studies in this laboratory. α-Amyrin (145), β-amyrin (146), 3β, 29-dihydroxyolean-12-ene (151) and 3β, llα-dihydroxyolean-12-ene (152) are known triterpenes possessing an oleanene-type skeleton and are isolated for the first time from the TRP-4a cell line. Tingenone (148) and 22β-hydroxytingenone (150) are quinone methide triterpenes, also isolated for the first time from the TRP-4a cell line. Similarly, the novel diterpene, 12-methoxyabieta-8, 11, 13- trien-3α-ol (147) and the novel triterpene, methyl-22β-hydroxy-3, 21-dioxo-D:A-friedo-29-noroleanan-24-oate (149), a member of the friedelane family, are isolated for the first time. A biosynthetic pathway, based on the isolation of 149 and its structural similarity to polpunonic acid (55) and 22β-hydroxytingen6ne (150), is postulated for the quinone methides. The cytotoxic diterpenes, tripdiolide (1) and triptolide (2) and the hydroxy acid, 160, isolated as the methyl ester, 124, have been previously reported from this laboratory. Tripdiolide (1) and triptolide (2) have been shown to possess strong antifertility and immunosuppressive activities. In another aspect of our program, biotransformation studies of the synthetic precursors, 19 (4➙3)abeo-abieta-2, 8, 11, 13-tetraen-19-ol (171) and 19-hydroxy-18(4➙3)abeo-abieta-3, 8, 11, 13-tetraen-18-oic acid lactone (91), and the radioactive congeners, 182 and 209, were carried out using the TRP-4a cell line. It was hoped that the data obtained might shed some light on the "late stage" biosynthetic pathway of the diterpene triepoxides, tripdiolide (1) and triptolide (2). Synthesis of 171 was achieved in 5 steps from dehydroabietic acid (80). The radioactive congener, 182, was synthesised using ¹⁴C-paraformaldehyde with 0.4% incorporation of the radiolabel. Biotransformation of 171 using the TRP-4a cell line yielded 19(4➙3)abeo-abieta-2, 8, 11, 13-tetraen-19-al (185) and 19(4➙3)abeo-abieta-2, 8, 11, 13-tetraen-19-oic acid (186) for spectral identification. Biotransformation of 182 yielded the aldehyde, 183 (33.2%) and the acid, 184 (51.9%), the radioactive congeners of 185 and 186 respectively. Synthesis of 91 was achieved in 4 steps from dehydroabietic acid (80). The radioactive congener, 209, was synthesised using ¹⁴C-methyl iodide via ¹⁴C-dimethylsulphonium methylide, with 0.6% incorporation of the radiolabel. Biotransformation of 91 using TRP-4a tissue cultures yielded 19-hydroxy-7-oxo-18(4➙3)abeo-abieta-3, 8, 11, 13-tetraen-18-oic acid lactone (214), 2β, 19-dihydroxy-7-oxo-18(4➙3)abeo-abieta-3, 8, 11, 13-tetraen-18-oic acid lactone (215), 7β, 19-dihydroxy-18(4➙3)abeo-abieta-3, 8, 11, 13-tetraen-18-oic acid lactone (216) and 2β 19-dihydroxy-18(4➙3)abeo-abieta-3, 8, 11, 13-tetraen-18-oic acid lactone (96), for spectral identification. Biotransformation of 209 yielded the ketone, 210 (56.7%), the hydroxy ketone, 211 (5.9%), the benzylic alcohol, 212 (9.6%) and the C2 alcohol, 213 (6.8%), the radioactive congeners of 214,215,216 and 96 respectively. A biosynthetic pathway to the diterpene triepoxides is postulated based on the oxygenated biotransformation products. [formulas omitted] / Science, Faculty of / Chemistry, Department of / Graduate

Charles University Faculty of Pharmacy in Hradec Králové Department of Biochemical Sciences Candidate: Bc. Lenka Martínková Supervisor: RNDr. Lucie Raisová Stuchlíková, Ph.D. Title of diploma thesis: Biotransformation of fenbedazole in soya (Glycine max) Veterinary drugs are used in large amounts in modern husbandry for treatment and prevention of diseases in animals. Anthelmintics administered to animals enter into environment primarily through its excretion in faeces or urine. Following excretion, drugs may persist in the environment and impact non-target organisms. Plants are able to uptake xenobiotics, including drugs, and detoxify them via biotransformation. However, only drug biotransformation into non-toxic and stable metabolites and their consequent accumulation in plants represent drug detoxification. For that reasons, knowledge of biotransformation pathways of drug in plants is very important. Soybean plants, eventually seeds, are further used in agriculture as feed for cattle and absorbed anthelmintics including their metabolites can enter the food chain. The results showed that fenbendazole entered plant and enzymatic systems of plant were able to biotransform fenbendazole via several reactions. We found differences in the metabolites between the roots, leaves, seeds and pods of soybean.

Biocatalysis is considered a green and environmentally friendly technology. Therefore, novel enzymes and enzymatic systems, together with cascades and protein engineering approaches, are in high demand. Here, three very different biocatalytic approaches have been studied. First, the richness of enzymes in the Red Sea brine pools has been assessed, and the discovery and characterization of a novel halophilic γ-carbonic anhydrase is described, together with the protein engineering approach, which boosted the initial catalytic activity of the γ- carbonic anhydrase. The understanding of polyextremophilicity principles from enzymes from the Red Sea brine pool, contributes to the bioengineering effort of turning mesophilic enzymes into more stable variants. Next, focus is given to the use of amine-transaminases in cascades for chiral amine synthesis. This resulted in the development of a self-sufficient sustainable cascade for chiral and non-chiral amine synthesis. This cascade was achieved by combining a lysine decarboxylase with an amine-transaminase to generate a cheap amino donor source for a more sustainable reaction economy. Finally, gas vesicle nanoparticles are functionalized by various engineering principles to create floating platforms for the immobilization of enzymes. The proof-of-concept was achieved by anchoring a phytase via anchoring peptides on the gas vesicle nanoparticles surface. These bioengineering approaches contributed to the effort of generating first principles for protein engineering.

Diese Arbeit befasst sich mit der Untersuchung des Metabolismus sowie der Reaktivität verschiedener Wirk- und Arzneistoffe mittels flüssigchromatographischer und massen-spektrometrischer Methoden, sie gliedert sich dabei in vier Projekte. Zur Bestimmung des Metabolitenprofils wurde ein passendes In-vitro-Inkubationssystem mit Cytochrom-P-450-Systemen entwickelt. So wurden der Metabolismus und die Pharmakokinetik der Mip-Inhibitoren SF110, SF235 und SF354 gegen Legionellen, sowie neuer antitrypanosomaler Verbindungen MB209, MB343 und MB444 und von Daptomycin bestimmt. Darüber hinaus wurde die antibakterielle Aktivität des Daptomycins gegenüber einem unbekannten Staphylokokkus-Stammes S. sciuri ermittelt. Außerdem wurden Reaktivitätsuntersuchungen neu synthetisierter Inhibitoren gegen Tuberkulose und S. aureus durchgeführt. Die untersuchten Mip-Inhibitoren lieferten ein Metabolitenprofil, welches durch Ester- und Amidhydrolysen sowie Hydroxylierungen geprägt wurde. Die Verbindung SF110 schien dabei bereits eine gewisse Instabilität der Esterbindung aufzuweisen, da auch im Blindwert entsprechende Spaltprodukte identifiziert werden konnten. Die Hauptmetabolite von SF235 und SF354 bildeten sich durch unterschiedliche Hydrolysen, da die Spaltung des Moleküls von den jeweiligen Substituenten abhängig ist. Innerhalb dieser Substanzklasse dominiert die mikrosomale Enzymkatalyse, da der größte metabolische Umsatz sowie die meisten Metabolite mittels mikrosomaler Fraktion des Menschen bzw. der Maus gefunden wurden. Die Klasse der Mip-Inhibitoren wird somit vor allem durch Cytochrom-P-450-Enzyme umgesetzt, wobei die Hydrophilie durch Einführung polarer OH-Gruppen der Moleküle erhöht wird. Die Hydroxylierung scheint dabei positionsspezifisch, bedingt durch sterische Hinderungen oder dirigierende Einflüsse, abzulaufen. Stabilitätsvergleiche zwischen SF110, SF235 und SF354 zeigten, dass die Einführung einer Amidbindung anstelle der korrespondierenden Esterbindung die Substanzklasse maßgeblich metabolisch stabilisiert. Im Rahmen des murinen In-vivo-Metabolismus wurde beobachtet, dass SF235 einem deutlich stärkeren Metabolismus unterlag als SF354 und sich der Metabolismus vor allem innerhalb der ersten 30 min vollzog. Demgegenüber zeigten die In-vitro-Ergebnisse gegenteilige Ergebnisse, bei denen SF354 die am stärksten metabolisierte Substanz war. Diese widersprüchlichen Ergebnisse deuten darauf hin, dass In-vitro-Modelle nur als Anhaltspunkt verwendet werden sollten, um mögliche Trends abzuleiten. Metabolismusstudien der Chinolonamide, die gegen die afrikanische Schlafkrankheit wirken sollen, veranschaulichten, dass die größte enzymatische Umsetzung aller drei getesteten Verbindungen mittels cytosolischer Fraktion erfolgte. Die Enzymreaktionen werden vermutlich durch ALDH bzw. MAO dominiert und nicht durch CYP bzw. FMO. Die gebildeten Metabolite in den verschiedenen Fraktionen unterlagen (ω-1)-Oxidationen, N-Desalkylierungen, Amidhydrolysen und aromatischen Hydroxylierungen. Auffallend war, dass eine Hydroxylierung am aromatischen Benzylring nur erfolgen konnte, sofern der Benzylaromat keinen Fluorsubstitutenten trug, da dieser desaktivierend wirkte. Die aromatische Hydroxylierung am Chinolonamid erfolgte dagegen bei allen drei Substanzen. Es wurde somit lediglich eine Hydroxylierung am Benzylring von MB343 festgestellt. Die enzymatische Aktivität aller Substanzen folgte einer Reaktionskinetik 1. Ordnung. Die unterschiedlichen Stabilitäten der Substanzen zeigten einen deutlichen Trend: MB209 wurde, da es die instabilste Verbindung darstellt, im größten Maße umgesetzt, gefolgt von den stabileren Derivaten MB343 und MB444. Die Untersuchung der enzymatischen Aktivitäten zeigte, dass die drei Substanzen, verglichen mit der Leitstruktur GHQ168, eine um den Faktor zehn geringere Aktivität aufwiesen [19]. Aufgrund der eingeführten Fluoratome weisen die Substanzen somit eine wesentlich höhere Stabilität auf. Diese Ergebnisse wurden durch die Untersuchung der Halbwertszeit bestätigt, bei der MB444 den höchsten Wert besaß. Weiterhin ist die Position des Fluorsubstituenten am Chinolongerüst ausschlaggebend für die metabolische Stabilität, wobei MB444 aufgrund des para-Fluorsubstituenten am Chinolonamid die stabilste Verbindung darstellt. Durch Inkubation von Daptomycin mit unterschiedlichen S. sciuri-Isolaten wurde ein möglicher Inaktivierungsmechanismus beobachtet, bei dem das Antibiotikum durch Spaltung des cyclischen Aminosäureringes, durch Deacylierung des Fettsäureschwanzes, einer Kombination beider Mechanismen oder durch eine Spaltung des heteroaromatischen Ringsystems von Tryptophan inaktiviert wurde. Die Proteasen des Daptomycin-resistenten S. sciuri-Isolats TS92 führten zu einem Daptomycinabbau von 35 %, unabhängig von der eingesetzten Menge des Arzneistoffes. Das Ausmaß des Abbaus scheint darüber hinaus vom eingesetzten Inkubationsmedium abhängig zu sein, da die Proteasen voraussichtlich auf ein bestimmtes Nährmedium angewiesen sind. Der sensitive S. sciuri-Stamm TS93 lieferte die höchste Abbaurate an Daptomycin mit 55 % und widerlegt damit die Vermutung, dass Daptomycin die geringste antibakterielle Aktivität gegenüber diesem S. sciuri-Stamm aufweist. Im In-vitro-Metabolismus zeigte Daptomycin insgesamt eine sehr geringe Umsetzungsmenge mit maximal 5 % nach 4 h und einer geringen Metabolitenbildung. Hier wurde nur ein Metabolit gefunden, welcher auch mittels S. sciuri-Inkubation identifiziert wurde. Dieser Mechanismus könnte somit auf anderem Wege verlaufen. Die Reaktivitätsstudien der kovalenten Inhibitoren der FadA5-Thiolase gegen Tuberkulose zeigten, dass nur die Verbindungen C1 und C4 eine Reaktivität gegenüber der Aminosäure Cystein93 im aktiven Zentrum besaßen, die somit für den gewünschten Einsatzzweck geeignet sein könnten. Weiterhin wurde bei den kovalenten Inhibitoren der Enoyl-ACP-Reduktase mit dem Enzym FabI, welches im aktiven Zentrum ein Tyrosin besitzt, keine Reaktion festgestellt, da keine Addukte identifiziert wurden. Dies ist vermutlich auf die Unlöslichkeit im verwendeten TRIS-Puffer zurückzuführen. / This work deals with the investigation of the metabolism as well as the reactivity of different drug candidates as well as active pharmaceutical substances by means of liquid chromatographic and mass spectrometric methods. It is divided into four projects. In order to determine the metabolite profile, a suitable in-vitro incubation system using cytochrome P-450-systems was developed. Thus, the metabolism and pharmacokinetics of the Mip inhibitors SF110, SF235, and SF354 against Legionella, as well as of new antitrypanosomal compounds MB209, MB343, and MB444 and of daptomycin were determined. In addition, the antibacterial activity of daptomycin against an unknown Staphylococcus strain S. sciuri was determined. In addition, reactivity studies of newly synthesized inhibitors against tuberculosis and S. aureus were performed. The Mip inhibitors investigated showed a metabolite profile being characterized by ester and amide hydrolysis as well as hydroxylation. The ester moiety of compound SF110 seemed to be unstable, as metabolites could be also identified in the negative control. The major metabolites of SF235 and SF354 were formed by different hydrolyses, whereby the cleavage mechanism of the molecule is dependent on the respective substituents. The substance class is dominated by microsomal enzyme catalysis, as the highest metabolic turnover and, eventually, the most metabolites were found using a microsomal fraction of the human and mouse. The class of Mip inhibitors is thus represented mainly by cleavage due to cytochrome P-450 enzymes, wherein the hydrophilicity of the substrate is increased by introducing polar hydroxyl groups. Hydroxylation seems to be site specific due to steric hindrance or directing influences. Comparing the stability of SF110, SF235, and SF354 revealed that introducing an amide bond instead of an ester bond significantly stabilizes the substance class metabolically. In murine in vivo metabolism results, SF235 was found to be metabolized more significantly than SF354 within the first 30 min of incubation. In contrast, the in vitro results showed the opposite. SF354 was the most metabolized substance. The contradictory results suggest that in vitro models should only be used as an indicator to derive possible trends. Metabolism studies of quinolonamides active against African sleeping sickness, demonstrated that the highest enzymatic conversion of all three tested compounds was caused by the cytosol fraction. The enzyme reactions are probably catalyzed by ALDH or MAO and not by CYP or FMO, respectively. The formed metabolites found in various fractions were subject to (ω-1)-oxidations, N-dealkylations, amide hydrolyses, and hydroxylations. It was observed that hydroxylation could only take place on the aromatic benzyl ring if it did not carry any fluorine substituents having a deactivating effect. The aromatic hydroxylation of the quinolonamide, however, was carried out in all three substances. Thus, only hydroxylation on the benzyl ring of MB343 was observed. The enzymatic activity of all substances followed a first-order kinetic. The different stabilities of the substances had a clear trend: MB209 showed the highest enzymatic activity as it represents the most unstable compound, followed by MB343 and MB444. The enzymatic activities of the three substances were ten times lower compared to the enzymatic activity of lead structure GHQ168 [19], which exhibits a much higher stability due to the fluorine atoms. These results were confirmed by a half-life study in which MB444 was the most stable compound. The position of the fluorine substituent on the quinolone determines the metabolic stability, making MB444 the most stable compound because it carries a p-fluorine substituent on the quinolonamide. When incubating Daptomycin with different S. sciuri isolates, a possible inactivation mechanism of the antibiotic agent was observed in which the cyclic amino acid ring was opened, the fatty acid tail deacylated, or a combination of both mechanisms as well as the heteroaromatic ring system of tryptophan was cleaved. The proteases of the daptomycin-resistant S. sciuri isolate TS92 led to a daptomycin degradation of 35%, regardless of the initial concentration used. The degradation also seems to depend on the incubation medium since the proteases probably rely on a specific nutrient medium. The sensitive S. sciuri strain TS93 showed the highest degradation rate of daptomycin with 55 % and thus refutes the assumption that it has the smallest antibacterial sensitivity against daptomycin. Overall, DAP showed a very low in vitro metabolism with a conversion rate of maximum 5% after 4 h and a low metabolic rate. Here, only one metabolite could be found which was also identified by means of S. sciuri incubation. Thus, this mechanism could proceed in a different way. The reactivity studies of the covalent inhibitors of the thiolase of the FadA5 enzyme against tuberculosis showed that only compounds C1 and C4 targeted cysteine93, thus being suitable for the desired purpose. Furthermore, no reaction was observed for in the covalent inhibitors of the enoyl-ACP reductase with the enzyme FabI, which carries a tyrosine in the active site, since no adducts were identified. This is probably due to the insolubility in the TRIS buffer.

No description available.

Tableau d’honneur de la Faculté des études supérieures et postdoctorales, 2012-2013. / Une surexposition aux hormones stéroïdiennes peut entraîner dans certains tissus une induction de la prolifération et de la survie cellulaires menant à l'hyperplasie puis à la néoplasie. Les travaux de doctorat ont d'abord porté sur les hormones stéroïdiennes, principalement les oestrogènes, en lien avec le cancer de l'endomètre. La quantification de ces hormones au niveau circulant a permis de révéler que le profil hormonal est significativement différent chez les femmes atteintes d'un cancer comparativement à celui des femmes en santé. Les oestrogènes sont les hormones qui augmentent le plus en présence d'un cancer de l'endomètre, bien que les androgènes et les précurseurs surrénaliens circulants soient également plus élevés que chez les femmes saines. De plus, les oestrogènes en circulation sont associés à certaines caractéristiques clinico-pathologiques. Notamment, les femmes atteintes d'un cancer de type I (endométrioïde), de bas grade et/ou non-invasif présentent des niveaux d'oestrogènes circulants significativement plus élevés que les femmes atteintes d'un cancer de type II, de grade élevé et/ou invasif. Les analyses d'expression d'ARNm des gènes de la stéroïdogénèse dans les tumeurs vont de pair avec les dosages hormonaux et supportent l'hypothèse d'une augmentation de la synthèse des oestrogènes dans les tumeurs comparativement au tissu normal péritumoral. En effet, il semble que le sulfate d'oestrone, qui constitue un réservoir plasmatique d'oestrogènes, soit la source principale de production d'estradiol chez les femmes atteintes d'un cancer, ce qui est appuyé par l'analyse de corrélation des niveaux hormonaux en circulation. De plus, il semble y avoir une augmentation de l'inactivation du 2-méthoxyestradiol à effet protecteur, puisque l'expression en ARN des enzymes nécessaires à son catabolisme est augmentée dans les tumeurs. Cette hypothèse est supportée par l'observation que les niveaux circulants des dérivés glucuronides inactifs du 2-méthoxyestradiol sont plus élevés en présence de néoplasie. Les travaux ont également porté sur l'influence des variations héréditaires sur l'évolution du cancer de la prostate suite à un traitement telle la prostatectomie radicale ou la thérapie de privation d'androgènes. Les polymorphismes génétiques de gènes candidats liés aux voies de synthèse et de métabolisme des hormones stéroïdiennes ont été associés à une modification du risque de récidive biochimique, de progression clinique et de mortalité chez une population de Caucasiens atteints d'un cancer de la prostate. Des résultats similaires ont été obtenus pour les patients d'origine asiatique. Ainsi, la génétique du patient semble influencer l'évolution du cancer après traitement. En parallèle, l'analyse des hormones stéroïdiennes circulantes en lien avec ces variations génétiques supporte une altération de la synthèse et du métabolisme hormonal favorisant l'évolution tumorale. En conclusion, les données supportent que les hormones stéroïdiennes affectent le développement et l'évolution de cancers hormonodépendants, tels ceux de l'endomètre et de la prostate. Une meilleure compréhension du rôle joué par ces hormones et des facteurs génétiques les influençant pourrait permettre de développer de nouveaux marqueurs pronostiques et des traitements plus ciblés visant à contrer ces maladies et, éventuellement, de faire progresser la médecine personnalisée dans ce domaine.

Bluegill were exposed to 3 and 30 pg/L lindane and 20 and 200 pg/L naphthalene to determine uptake rate constants, K1 depuration rate constants, K2, and bioconcentration factors, BCF. Correlations were determined between lipid normalized and non-lipid normalized BCFs, and between observed Kl, K2 and BCFs and predicted values. The K1 values for both chemicals and concentrations were similar. The K2 values were different (1.04 day~1, 0.46 day 1). Naphthalene was more rapid. BCFs for lindane (315) and naphthalene (98) were different. Lipid normalized BCFs for naphthalene were more variable than non-lipid normalized BCFs. The reverse was observed for lindane BCFs. Predicted K1, K2 , and BCFs were in agreement with observed values.

Afin d’étudier la santé d’un écosystème marin et le potentiel toxique d’une contamination telle que celle liée à la présence d’hydrocarbures aromatiques polycycliques (HAP), il est nécessaire, outre de connaître les niveaux de contamination du milieu, de pouvoir accéder à la fraction toxique à laquelle les organismes aquatiques ont été exposés et de connaître les effets toxiques des contaminants incriminés. L’exposition et la contamination des organismes aquatiques aux HAP ont généralement été évaluées par le dosage des HAP bioaccumulés dans les tissus. Or, cette approche est critiquable si l'on tient compte des capacités de biotransformation des organismes, notamment des vertébrés, et des propriétés toxiques des produits de transformation formés. Dans ce contexte, l’objectif de cette thèse est d’étudier les phénomènes de bioccumulation et de biotransformation des HAP chez les organismes marins via l’étude des métabolites de HAP. Un effort de validation de biomarqueurs pertinents pour évaluer la génotoxicité des HAP en lien avec la contamination chimique des tissus et la production de métabolites est nécessaire. Des méthodes de dosage des métabolites de HAP dans les matrices biologiques ont tout d’abord été mises au point. Ces outils analytiques sensibles, innovants et performants ont ensuite été appliqués lors d’expositions de poissons à des HAP via différentes voies de contamination en milieu contrôlé. Ils ont permis une meilleure connaissance des phénomènes de biotransformation des HAP. Enfin, des études de terrain ont été réalisées, notamment dans le cadre de l’étude de la contamination de la Baie de Seine, montrant l’applicabilité du dosage des métabolites de HAP dans l’évaluation de l’exposition des organismes aux HAP en milieu naturel. Dans le cadre d’une approche intégrée chimie/biologie, ces travaux ont permis d’apporter une contribution dans le transfert méthodologique des biomarqueurs de génotoxicité des HAP pour des applications en surveillance de l’Atlantique Nord et notamment dans la Manche. / In order to study the health of a marine ecosystem and the toxic potential of a contamination such as that related to the presence of polycyclic aromatic hydrocarbons (PAHs), it is necessary, in addition to the determination of environmental contamination levels, to have access to the fraction for aquatic organisms have been exposed to and to identify the toxic effects of the contaminants. The exposure and contamination of aquatic organisms to PAHs have generally been evaluated by the quantification of bioaccumulated PAHs in tissues. However, this approach is criticable when taking into account the biotransformation capabilities of organisms such as vertebrates and the toxic properties of biotransformation products. In this way, the aim of this study is to study PAH bioaccumulation and biotransformation phenomena through the PAH metabolites study. An effort for the validation of relevant biomarkers to evaluate the link between the genotoxicity of PAHs, PAHs body burden and PAH metabolites production, is necessary. Analytical techniques to quantify PAH metabolites in biological matrices have first been set up. Then, these sensible, innovating and powerful analytical tools have been applied to the study of fish exposures to PAHs through differents contamination sources in controlled conditions. This allowed to have a better understanding of PAH biotransformation phenomena. Finally, field studies have been led, notably to study the contamination of the Seine bay, demonstrating the applicability of the quantification of PAH metabolites to evaluate the exposure and the contamination of organisms to PAHs in natural environment. Within the framework of an integrated approach chemistry/biology, this work led to a contribution in the methodological transfer of biomarkers of PAH genotoxicity